003000 — Bukwang Pharm Co Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareAdventurousSmall CapNeutral

Annual cashflow statement for Bukwang Pharm Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	ARS	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	-8,300	3,787	-1,033	-39,569	-2,970
Depreciation
Amortisation
Non-Cash Items	20,755	7,676	8,159	490	5,643
Unusual Items
Purchased R&D
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital	-17,890	10,219	4,219	25,425	27,582
Change in Accounts Receivable
Change in Inventories
Change in Other Assets
Change in Accounts Payable
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities	723	26,525	16,461	-9,362	34,362
Capital Expenditures	-1,954	-790	-4,990	-2,835	-2,612
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items	15,002	5,539	1,839	516	-25,115
Sale of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Change in Net Investments
Purchase of Investments
Sale of Intangible Assets
Other Investing Cash Flow
Cash from Investing Activities	13,048	4,749	-3,151	-2,319	-27,727
Financing Cash Flow Items	-947	-291	-3,218	-1,139	-67,286
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	28,232	-27,485	-10,398	76,839	-67,651
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	41,706	3,486	2,740	65,710	-61,136